Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

Background: With the increase in the aging population, there is a pressing need to provide effective treatment options for individuals with Alzheimer's disease (AD). Memantine is an N-methyl-D-aspartate receptor antagonist used to treat AD in > 80 countries worldwide, and studies in the USA...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Yu, Kitamura, Shin, Homma, Akira, Shiosakai, Kazuhito, Matsui, Daiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025599/
https://www.ncbi.nlm.nih.gov/pubmed/24673497
http://dx.doi.org/10.1517/14656566.2014.902446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025599/
https://www.ncbi.nlm.nih.gov/pubmed/24673497
http://dx.doi.org/10.1517/14656566.2014.902446

Ejemplares similares